Breaking News - The Fly

Open Search

ARVN

Arvinas

$

()

Arvinas appoints Randy Teel Chief Business Officer

ARVN

4/24/2024 - 16:41pm

Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call

ARVN , PFE

4/15/2024 - 12:50pm

Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call

ARVN , PFE

4/15/2024 - 11:49am

Arvinas price target lowered by $3 at H.C. Wainwright, here's why

ARVN

4/15/2024 - 06:47am

Arvinas enters exclusive strategic license agreement with Novartis for ARV-766

ARVN , NVS

4/11/2024 - 07:05am

Arvinas names Noah Berkowitz as Chief Medical Officer

ARVN

3/18/2024 - 16:46pm

Arvinas price target raised by $34 at Barclays, here's why

ARVN

2/29/2024 - 05:52am

Arvinas price target raised by $26 at Wedbush, here's why

ARVN

2/28/2024 - 08:46am

Arvinas VERITAC-2 trial timelines not changed, says Oppenheimer

ARVN

2/27/2024 - 16:23pm

Arvinas expects cash to fund operations into 2027

ARVN

2/27/2024 - 07:02am

Arvinas reports Q4 EPS ($2.53), consensus ($1.27)

ARVN

2/27/2024 - 07:01am

Arvinas announces resignation of CFO Sean Cassidy

ARVN

2/20/2024 - 16:26pm

Arvinas announces first-in-human dosing of ARV-102

ARVN

2/20/2024 - 07:12am

Carrick announces first patient dosed in trial of samuraciclib, vepdegestrant

ARVN , PFE

2/14/2024 - 08:22am

Arvinas just downgraded at Citi, here's why

ARVN

2/14/2024 - 07:35am